Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2003
10/30/2003CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482042A1 Methods for treating an autoimmune disease using a soluble ctla4 molecule and a dmard or nsaid
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481512A1 Peptide inhibitors of protein kinase c.gamma. for pain management
10/30/2003CA2481120A1 Method for treating and preventing hyperparathyroidism
10/30/2003CA2481104A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation
10/30/2003CA2481085A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2466229A1 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/29/2003EP1357186A1 Novel proteins and dnas thereof
10/29/2003EP1357184A2 Novel cis-element decoys useful as anti-tumor therapeutics
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357131A2 Treatment of lupus nephritis with anti-CD4OL compounds
10/29/2003EP1357130A1 Basic fibroblastic growth factor with a specific collagen binding domain
10/29/2003EP1357129A2 Novel physiologically active peptide and use thereof
10/29/2003EP1356824A2 88KDA tumorigenic growth factor and antagonists
10/29/2003EP1356821A2 Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response INDUCED BY ADP-RIBOSYLATING EXOTOXIN
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1356819A1 Use of proteasome/ubiquitination inhibitors and/or MMP inhibitors alone or in combination with a growth hormone for treating /preventing catabolic conditions
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356809A1 Sustained release preparations
10/29/2003EP1356733A2 Pesticidal and antiparasitic compositions
10/29/2003EP1356298A2 Diagnosis and treatment of disease
10/29/2003EP1356293A2 Compositions and methods involving staphylococcus aureus protein staau-r9
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356110A2 Non-invasive method for detecting target rna
10/29/2003EP1356107A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356074A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356057A2 56634, a novel human phosphatidylinositol 4-phosphate 5-kinase family member and uses thereof
10/29/2003EP1356053A2 Histone deacetylase inhibitors in diagnosis and treatment of thyroid neoplasms
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356021A2 Method to remove citrate and aluminum from proteins
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355944A2 Rtvp based compositions and methods for the treatment of prostate cancer
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355941A2 Long lasting growth hormone releasing factor derivatives
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355939A2 Interferons, uses and compositions related thereto
10/29/2003EP1355938A2 Composition for treatment of and method of monitoring hepatitis c virus using interferon-tau
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355925A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
10/29/2003EP1355924A2 Armed peptides
10/29/2003EP1355923A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355920A1 Extractive purification of lipopeptide antibiotics
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355916A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
10/29/2003EP1355910A1 Formulation of boronic acid compounds
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP1355674A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors
10/29/2003EP1355672A2 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
10/29/2003EP1355669A2 Augmented cognitive training
10/29/2003EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355664A2 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
10/29/2003EP1355662A2 Method of preventing t cell-mediated responses by the use of the major histocompatibility complex class ii analog protein (map protein) from staphylococcus aureus
10/29/2003EP1355660A2 Therapeutic modulation of the tumor inflammatory response
10/29/2003EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis
10/29/2003EP1355658A1 Pyk2 phosphorylation by her3 induces tumor invasion
10/29/2003EP1355657A2 Gssp3 polynucleotides and polypeptides and uses thereof
10/29/2003EP1355656A2 Red blood cell as vehicle for agent-membrane translocation sequence conjugate
10/29/2003EP1355655A2 Compositions and methods for improving kidney function
10/29/2003EP1355653A2 Stimulation of thymus for vaccination development
10/29/2003EP1355651A2 Treatment of diabetes mellitus using vardenafil
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP1355541A1 Alpha-lactalbumin as prebiotic agent
10/29/2003EP1235787B1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS
10/29/2003EP1204429B1 Sustained release formulation of a peptide
10/29/2003EP1175453B1 Differentially acting op detoxifying sponges
10/29/2003EP1161230B1 Transdermal therapy system and method for producing the same
10/29/2003EP1094834B1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein
10/29/2003EP1082129B1 Method for the treatment of fertility disorders
10/29/2003EP1017370B1 MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
10/29/2003EP1012166B1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
10/29/2003EP1009804B1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
10/29/2003EP1007093B1 Treatment of disorders using interleukin-9
10/29/2003EP0996728B1 IMPROVED ANTI-IgE ANTIBODIES AND METHODS OF IMPROVING ANTIBODIES
1 ... 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 1760 1761 1762 1763 ... 3163